 |
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
1 term
|
 |
|
Biochemical function
|
hormone activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
94:2975-2980
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of desheptapeptide(B24-B30)insulin at 1.6 A resolution: implications for receptor binding.
|
|
S.J.Bao,
D.L.Xie,
J.P.Zhang,
W.R.Chang,
D.C.Liang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of desheptapeptide (B24-B30) insulin (DHPI), a virtually
inactive analog of insulin, was determined at 1.6 A resolution. In the refined
structure model, DHPI retains three alpha-helices (A1-A8, A12-A18, and B9-B19)
as its structural framework, while great conformational changes occur in the N
and C termini of B-chain. The beta-turn, which lies in B20-B30 in insulin and
insulin analogs with high potency, no longer exists in DHPI. Relative motion is
observed among the three alpha-helices, each as a rigid functional group. In
contrast, a region covering B5-B6 and A6-A11 exhibits a relatively stable
conformation. We interpret our results as identifying: (i) the importance of
beta-turn in determining the receptor-binding potency of insulin and (ii) a
leading role of PheB24 in maintaining the beta-turn structure.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. The overall structure of DHPI. (a) A stereo ribbon
diagram of DHPI showing view along the local 2-fold axis near
(0,0,Z). (b) Stereo C trace of
two DHPI molecules, with every fifth residue^ labeled in each
chain. Residues are labeled as in Fig. 1. [This figure was
produced using MOLSCRIPT (28).
|
 |
Figure 4.
Fig. 4. Contacts of two monomers of DHPI or 2Zn insulin in an
asymmetric unit. Molecule 1 of DHPI or 2Zn insulin is shown in
boldface^ while molecule 2 is shown in regular type. (a)
Contacts through hydrophobic interfaces in two DHPI monomers.
The residues involved^ in the hydrophobic interaction are
highlighted in boldface lines. A hydrogen bond linking Cys111-O
and Arg422-NE is shown with a dotted line. (b) Contacts through
-strands of
C-terminal B-chains in 2Zn insulin dimer. The hydrogen bonds are
shown with dotted lines, with bonding residues labeled. Residues
are labeled as in Fig. 1. [This figure was produced using
MOLSCRIPT (28).
|
 |
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.Le Flem,
J.Pecher,
V.Le Flem-Bonhomme,
A.Withdrawn,
J.Rochette,
J.P.Pujol,
and
P.Bogdanowicz
(2009).
Human insulin A-chain peptide analog(s) with in vitro biological activity.
|
| |
Cell Biochem Funct, 27,
370-377.
|
 |
|
|
|
|
 |
J.L.Whittingham,
Z.Youshang,
L.Záková,
E.J.Dodson,
J.P.Turkenburg,
J.Brange,
and
G.G.Dodson
(2006).
I222 crystal form of despentapeptide (B26-B30) insulin provides new insights into the properties of monomeric insulin.
|
| |
Acta Crystallogr D Biol Crystallogr, 62,
505-511.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Alexandrov,
U.Lehnert,
N.Echols,
D.Milburn,
D.Engelman,
and
M.Gerstein
(2005).
Normal modes for predicting protein motions: a comprehensive database assessment and associated Web tool.
|
| |
Protein Sci, 14,
633-643.
|
 |
|
|
|
|
 |
Z.L.Wan,
B.Xu,
Y.C.Chu,
P.G.Katsoyannis,
and
M.A.Weiss
(2003).
Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding.
|
| |
Biochemistry, 42,
12770-12783.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Xu,
Q.X.Hua,
S.H.Nakagawa,
W.Jia,
Y.C.Chu,
P.G.Katsoyannis,
and
M.A.Weiss
(2002).
A cavity-forming mutation in insulin induces segmental unfolding of a surrounding alpha-helix.
|
| |
Protein Sci, 11,
104-116.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.H.Nakagawa,
H.S.Tager,
and
D.F.Steiner
(2000).
Mutational analysis of invariant valine B12 in insulin: implications for receptor binding.
|
| |
Biochemistry, 39,
15826-15835.
|
 |
|
|
|
|
 |
S.Bao,
J.Zhang,
W.Chang,
and
D.Liang
(1999).
Structure of desheptapeptide (B24-B30) insulin in a new crystal form.
|
| |
Sci China C Life Sci, 42,
267-273.
|
 |
|
|
|
|
 |
Z.P.Yao,
Z.H.Zeng,
H.M.Li,
Y.Zhang,
Y.M.Feng,
and
D.C.Wang
(1999).
Structure of an insulin dimer in an orthorhombic crystal: the structure analysis of a human insulin mutant (B9 Ser-->Glu).
|
| |
Acta Crystallogr D Biol Crystallogr, 55,
1524-1532.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.McInnes,
and
B.D.Sykes
(1997).
Growth factor receptors: structure, mechanism, and drug discovery.
|
| |
Biopolymers, 43,
339-366.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
| |